ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 53 filers reported holding ALIGOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,580 | -59.8% | 91,807 | -47.8% | 0.00% | – |
| Q2 2023 | $170,775 | +48278.2% | 175,875 | -56.4% | 0.00% | – |
| Q1 2023 | $353 | -0.3% | 403,370 | +8.6% | 0.00% | – |
| Q4 2022 | $354 | -99.9% | 371,319 | +11.8% | 0.00% | – |
| Q3 2022 | $365,000 | -35.1% | 332,131 | -28.5% | 0.00% | – |
| Q2 2022 | $562,000 | +104.4% | 464,409 | +1907.6% | 0.00% | – |
| Q4 2021 | $275,000 | -74.7% | 23,133 | -66.9% | 0.00% | -100.0% |
| Q3 2021 | $1,085,000 | +46.4% | 69,943 | +114.8% | 0.00% | 0.0% |
| Q1 2021 | $741,000 | – | 32,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $2,028,013 | 4.23% |
| TANG CAPITAL MANAGEMENT LLC | 3,424,800 | $2,993,275 | 0.45% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $649,570 | 0.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $552,269 | 0.23% |
| Vivo Capital, LLC | 3,547,030 | $3,100,104 | 0.22% |
| Newtyn Management, LLC | 1,021,461 | $892,757 | 0.18% |
| Logos Global Management LP | 1,000,000 | $874,000 | 0.12% |
| EcoR1 Capital, LLC | 3,948,360 | $3,450,867 | 0.11% |
| HHLR ADVISORS, LTD. | 2,309,764 | $2,018,734 | 0.04% |
| Baker Brothers Advisors | 2,076,400 | $1,814,774 | 0.01% |